Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
Tournigand C, Louvet C, de Gramont A, Lucchi E, Seitz JF, Mal F, Raymond E, Cady J, Carola E, Krulik M. Tournigand C, et al. Among authors: carola e. Cancer. 1997 Mar 15;79(6):1094-9. doi: 10.1002/(sici)1097-0142(19970315)79:6<1094::aid-cncr6>3.0.co;2-g. Cancer. 1997. PMID: 9070485 Clinical Trial.
Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen.
André T, Bensmaine MA, Louvet C, François E, Lucas V, Desseigne F, Beerblock K, Bouché O, Carola E, Merrouche Y, Morvan F, Dupont-André G, de Gramont A. André T, et al. Among authors: carola e. J Clin Oncol. 1999 Nov;17(11):3560-8. doi: 10.1200/JCO.1999.17.11.3560. J Clin Oncol. 1999. PMID: 10550155 Clinical Trial.
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.
Maindrault-Goebel F, Louvet C, André T, Carola E, Lotz JP, Molitor JL, Garcia ML, Gilles-Amar V, Izrael V, Krulik M, de Gramont A. Maindrault-Goebel F, et al. Among authors: carola e. Eur J Cancer. 1999 Sep;35(9):1338-42. doi: 10.1016/s0959-8049(99)00149-5. Eur J Cancer. 1999. PMID: 10658524 Clinical Trial.
CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR.
André T, Louvet C, Maindrault-Goebel F, Couteau C, Mabro M, Lotz JP, Gilles-Amar V, Krulik M, Carola E, Izrael V, de Gramont A. André T, et al. Among authors: carola e. Eur J Cancer. 1999 Sep;35(9):1343-7. doi: 10.1016/s0959-8049(99)00150-1. Eur J Cancer. 1999. PMID: 10658525 Clinical Trial.
Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR).
Maindrault-Goebel F, de Gramont A, Louvet C, André T, Carola E, Gilles V, Lotz JP, Tournigand C, Mabro M, Molitor JL, Artru P, Izrael V, Krulik M. Maindrault-Goebel F, et al. Among authors: carola e. Ann Oncol. 2000 Nov;11(11):1477-83. doi: 10.1023/a:1026520812351. Ann Oncol. 2000. PMID: 11142489 Free article. Clinical Trial.
High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).
Maindrault-Goebel F, de Gramont A, Louvet C, André T, Carola E, Mabro M, Artru P, Gilles V, Lotz JP, Izrael V, Krulik M; Oncology Multidisciplinary Research Group (GERCOR). Maindrault-Goebel F, et al. Among authors: carola e. Eur J Cancer. 2001 May;37(8):1000-5. doi: 10.1016/s0959-8049(01)00068-5. Eur J Cancer. 2001. PMID: 11334725 Clinical Trial.
47 results